Exactus Applauds CVS’s Decision to Sell CBD Products
Exactus Inc. Anticipates Many More National Drugstores to Follow Suit
DELRAY BEACH, Fla., March 22, 2019 (GLOBE NEWSWIRE) — Exactus Inc. (OTCQB:EXDI / OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products applauds CVS’s decision announced yesterday to begin selling CBD (cannabidiol) products in select stores throughout the country.
Exactus believes that the best way for patients and their physicians to feel confident in their choice of CBD products is to purchase them from a trusted name with a proven track record. There are many choices in the marketplace for CBD products, and it can be confusing for most consumers that are new to using CBD.
Philip J Young, CEO, stated, “Our driving mission and philosophy at Exactus is to farm, process and manufacture quality products. With the quality built into every product and tested to confirm that the potency, purity, and content that is on the label is indeed, exactly what is in the product. We are happy to see a national icon such as CVS make a statement and begin selling CBD. This is a trend that is sure to grow, and we believe we can take a leadership position in.”
Exactus recently announced that it had placed its first million-dollar product request from its partner and largest shareholder Ceed2Med. The availability of the tinctures, gel caps and topical lotions puts the company in a strong position in the market place. In addition, the availability of the remaining amount of the annual 2,500-kilogram product guarantee combined with the recently announced Exactus One World, 200 acre, Oregon farm ensures Exactus the quantity and capability sufficient to ensure product availability through 2020.
For information about Exactus’ products and availability, please call 804-205-5036 or email firstname.lastname@example.org.
Exactus, Inc., is a healthcare company pursuing opportunities in two distinct business segments. The company is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3% or less. That amount has not been shown to make a person feel “high.” THC is the psychoactive compound found in cannabis. The Company also has been pursuing businesses in point of care diagnostics.
Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under “Risk Factors” in Item 1A of our most recent Form 10-K for the fiscal year ended December 31, 2017 filed with the Securities and Exchange Commission (the “SEC”) on April 2, 2018 and under the heading “Risk Factors” in our subsequently filed Current Reports on Form 8-K filed with the SEC, and in our other filings and reports with the SEC. If any of these risks were to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See “Safe Harbor” below.
Safe Harbor – Forward Looking Statements
The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “anticipates,” “plans,” “expects,” “intends,” “will,” “potential,” “hope” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company’s periodic and current filings with the SEC, including the factors described in the sections entitled “Risk Factors”, copies of which may be obtained from the SEC’s website at www.sec.gov. The Company does not undertake any obligation to update forward-looking statements contained in this press release.
For more information:
SOURCE: Exactus Inc.
Source: Exactus, Inc.
Released March 22, 2019